Correlations between molecular profile and tumor location in Chinese patients with oligodendroglial tumors

被引:15
作者
Huang, L. [1 ,2 ]
Jiang, T. [1 ]
Yuan, F. [3 ]
Li, G. L. [3 ]
Liu, E. Z. [2 ]
Wang, Z. C. [3 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China
[2] Harbin Med Univ, Hosp 1, Dept Neurosurg, Harbin, Peoples R China
[3] Beijing Neurosurg Inst, Beijing 100050, Peoples R China
关键词
Oligodendroglial tumor; Molecular profile; Tumor location; DHPLC; LOH; 1p; 19q;
D O I
10.1016/j.clineuro.2008.06.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate possible correlations between molecular alterations and tumor location in Chinese patients with oligodendroglial tumors. Methods: A series of 105 gliomas, including 42 oligoastrocytomas, and two control groups of 28 oligodendrogliomas and 35 astrocytomas, were retrospectively reviewed. In each case, the radiologic picture and loss of heterozygosity (LOH) on chromosome 1p and 19q detected by denaturing high-performance liquid chromatography (DHPLC) were analyzed. Correlations between molecular profile and tumor location were made by chi-square and Fisher's exact tests. Results: Oligodendroglial tumors located in the nontemporal lobes were significantly more likely to have combination of LOH 1p and LOH 19q than tumors arising in the insula, temporal lobe, and temporal with another lobe (p, = 0.001). Subgroup analysis confirmed this finding in oligodendrogliomas (p, = 0.006), but the difference did not reach significance in the oligoastrocytoma group. although the trend was similar (p=0.067). In contrast to the oligodendroglial tumors, we detected no association between molecular alterations and location for diffuse astrocytomas. Conclusion: We conclude that molecular subsets of oligodendroglial tumors may arise preferentially in certain lobes of the brain, with tumors having LOH 1p and LOH 19q occurring most frequently in the nontemporal lobes. These findings suggest that molecular subsets of oligodendroglial tumors may arise from site-specific precursor cells, which has provided some information for the current management of these neoplasms in China. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:1020 / 1024
页数:5
相关论文
共 31 条
  • [1] Burger PC, 2002, BRAIN PATHOL, V12, P257
  • [2] Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
    Cairncross, Gregory
    Berkey, Brian
    Shaw, Edward
    Jenkins, Robert
    Scheithauer, Bernd
    Brachman, David
    Buckner, Jan
    Fink, Karen
    Souhami, Luis
    Laperierre, Normand
    Mehta, Minesh
    Curran, Walter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2707 - 2714
  • [3] Rapid detection of allelic losses in brain tumours using microsatellite repeat markers and high-performance liquid chromatography
    Chernova, OB
    Barnett, GH
    Cowell, JK
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (12) : 1889 - 1893
  • [4] Clonality of oligoastrocytomas
    Dong, ZQ
    Pang, JCS
    Tong, CYK
    Zhou, LF
    Ng, HK
    [J]. HUMAN PATHOLOGY, 2002, 33 (05) : 528 - 535
  • [5] Reclassification of oligoastrocytomas by loss of heterozygosity studies
    Eoli, Marica
    Bissola, Lorena
    Bruzzone, Maria Grazia
    Pollo, Bianca
    Maccagnano, Carmelo
    De Simone, Tiziana
    Valletta, Lorella
    Silvani, Antonio
    Bianchessi, D.
    Broggi, Giovanni
    Boiardi, Amerigo
    Finocchiaro, Gaetano
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (01) : 84 - 90
  • [6] Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading
    Giannini, C
    Scheithauer, BW
    Weaver, AL
    Burger, PC
    Kros, JM
    Mork, S
    Graeber, MB
    Bauserman, S
    Buckner, JC
    Burton, J
    Riepe, R
    Tazelaar, HD
    Nascimento, AG
    Crotty, T
    Keeney, GL
    Pernicone, P
    Altermatt, H
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (03) : 248 - 262
  • [7] Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions
    Hoang-Xuan, K
    Capelle, L
    Kujas, M
    Taillibert, S
    Duffau, H
    Lejeune, J
    Polivka, M
    Crinière, E
    Marie, Y
    Mokhtari, K
    Carpentier, AF
    Laigle, F
    Simon, JM
    Cornu, P
    Broët, P
    Sanson, M
    Delattre, JY
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3133 - 3138
  • [8] Temozolomide for low-grade gliomas - Predictive impact of 1p/19q loss on response and outcome
    Kaloshi, G.
    Benouaich-Amiel, A.
    Diakite, F.
    Taillibert, S.
    Lejeune, J.
    Laigle-Donadey, F.
    Renard, M.-A.
    Iraqi, W.
    Idbaih, A.
    Paris, S.
    Capelle, L.
    Duffau, H.
    Cornu, P.
    Simon, J.-M.
    Mokhtari, K.
    Polivka, M.
    Omuro, A.
    Carpentier, A.
    Sanson, M.
    Delattre, J.-Y.
    Hoang-Xuan, K.
    [J]. NEUROLOGY, 2007, 68 (21) : 1831 - 1836
  • [9] Determination of loss of heterozygosity in frozen and paraffin embedded tumors by denaturating high-performance liquid chromatography (DHPLC)
    Kleymenova, E
    Walker, CL
    [J]. JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2001, 47 (1-2): : 83 - 90
  • [10] SHARED ALLELIC LOSSES ON CHROMOSOMES 1P AND 19Q SUGGEST A COMMON ORIGIN OF OLIGODENDROGLIOMA AND OLIGOASTROCYTOMA
    KRAUS, JA
    KOOPMANN, J
    KASKEL, P
    MAINTZ, D
    BRANDNER, S
    SCHRAMM, J
    LOUIS, DN
    WIESTLER, OD
    VONDEIMLING, A
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (01) : 91 - 95